Varian Medical Systems Inc. (VAR)

132.75
0.98 0.74
NYSE : Health Technology
Prev Close 131.77
Day Low/High 132.10 / 133.13
52 Wk Low/High 101.42 / 133.41
Avg Volume 679.10K
Exchange NYSE
Shares Outstanding 90.78M
Market Cap 11.96B
EPS 1.60
P/E Ratio 33.28
Div & Yield N.A. (N.A)

Latest News

Varian Reports Results For First Quarter Of Fiscal Year 2019

Varian Reports Results For First Quarter Of Fiscal Year 2019

PALO ALTO, Calif., Jan.

Varian Showcases Radiotherapy Ecosystem At 2019 China Users Meeting

Varian Showcases Radiotherapy Ecosystem At 2019 China Users Meeting

WUHAN, China, Jan. 14, 2019 /PRNewswire/ -- With nearly 1,300 Chinese radiation oncology professionals in attendance and an additional 8,000 users watching via a live webcast, Varian (NYSE: VAR) recently held its 2019 China Users Meeting in Wuhan, China...

Varian To Present At The J.P. Morgan Healthcare Conference

Varian To Present At The J.P. Morgan Healthcare Conference

PALO ALTO, Calif., Dec.

The New #111 Most Shorted S&P 500 Component: Varian Medical Systems

The New #111 Most Shorted S&P 500 Component: Varian Medical Systems

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Varian Announces First Quarter Fiscal Year 2019 Earnings Release Date

Varian Announces First Quarter Fiscal Year 2019 Earnings Release Date

PALO ALTO, Calif., Dec.

Varian-Equipped Emory Proton Therapy Center Opens

Varian-Equipped Emory Proton Therapy Center Opens

PALO ALTO, Calif., Dec.

Varian Schedules Annual Stockholder Meeting In Palo Alto

Varian Schedules Annual Stockholder Meeting In Palo Alto

PALO ALTO, Calif., Dec.

HollandPTC Opens With ProBeam System From Varian

HollandPTC Opens With ProBeam System From Varian

PALO ALTO, Calif., Nov.

Varian Halcyon Treatment System Receives China NMPA Approval

Varian Halcyon Treatment System Receives China NMPA Approval

PALO ALTO, Calif., Nov.

Anat Ashkenazi Named To Varian Board Of Directors

Anat Ashkenazi Named To Varian Board Of Directors

PALO ALTO, Calif., Nov.

Varian To Present At The Citi Global Healthcare Conference

Varian To Present At The Citi Global Healthcare Conference

PALO ALTO, Calif., Nov.

Varian Publishes 2018 Sustainability Report

Varian Publishes 2018 Sustainability Report

PALO ALTO, Calif., Nov.

Beijing Cancer Hospital Utilizes Varian RapidPlan To Win IDC Digital Transformation Award

Beijing Cancer Hospital Utilizes Varian RapidPlan To Win IDC Digital Transformation Award

PALO ALTO, Calif. and BEIJING, Nov.

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

PALO ALTO, Calif., Oct.

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

PALO ALTO, Calif., Oct.

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Consortium focused on preclinical research, clinical implementation and advocacy

Varian Introduces New ProBeam 360° Proton Therapy System

Varian Introduces New ProBeam 360° Proton Therapy System

PALO ALTO, Calif., Oct.

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

PALO ALTO, Calif., Oct.

TheStreet Quant Rating: A (Buy)